Anti-obesity treatment rimonabant also decrease liver spoil and develop cholesterol intensities. Rimonabant is accessible in Europe in the product name Acomplia but is not accepted for utilize in the United States. Researcher make a research on rats of this treatement at the end of the treatment they find a decrease in the rodents` liver rise level of obese in the liver and sign in the blood representing liver spoil. A decrease of an inflammation-related protein thought to reason insulin conflict in the liver as well as cirrhosis.